Acarix AB (publ) (“Acarix” or the “Company”) today announced that Herning Hospital has placed the first commercial order for the CADScor®System for non-invasive, non-radiation acoustic detection of Coronary Artery Disease (CAD).
Press releases
Read more
Acarix AB (publ) (“Acarix” eller “Företaget”) tillkännagav idag att sjukhuset i Herning är första kommersiella beställare av CADScor®System för icke-invasiv akustisk detektering av kranskärlssjukdom (CAD)
In preparation for launch, Swedish/Danish Acarix AB’s (publ) (“Acarix”) CADScor®System will be on display at the British Cardiovascular Society Annual Meeting in Manchester, June 5-7.
Som förberedelse inför lansering visas Svensk/danska Acarix AB:s (publ) (“Acarix”) CADScor®System upp
på British Cardiovascular Society Annual Meeting i Manchester, 5-7 juni.
Första kvartalet 2017 har varit en intensiv tid för Acarix i och med förberedelserna inför kommersialiseringen av CADScor®System.
The first quarter of 2017 was a busy time for Acarix due to preparations for the commercialization of CADScor®System.
(Malmö, Sweden). Swedish/Danish medical device company Acarix AB (publ) today announced that it has won the Danish Design Award in the category Employment Growth.
(Malmö, Sverige). Svensk/danska medicintekniska företaget Acarix AB (publ) meddelade idag att det har vunnit Danish Design Award i kategorin Employment Growth.
In preparation for launch in the Swedish and Danish markets, Swedish/Danish Acarix AB’s (publ)
(“Acarix”) CADScor®System will be on display at the Swedish Society of Cardiology spring meeting in
Malmö, April 26-28.
In preparation for launch in the Swedish and Danish markets, Swedish/Danish Acarix AB’s (publ)
(“Acarix”) CADScor®System will be on display at the Swedish Society of Cardiology spring meeting in
Malmö, April 26-28.
Reports
In September the registration trial was published in the International Journal for Cardiovascular Imaging.
